This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Smiths Group announces demerger of Smiths Medical by H1’20, with plans for a UK listing.
Smiths Group H1 underlying revenues +2% (+3% excl. Medical), operating profit -2%, pre-tax profit -1%, free cash flow -37%. Interim dividend +2.2%. Reiterates full year guidance for “at least” 2% underlying revenue growth.
easyJet to keep EU ownership position under review following Brexit; currently 49.92% (excl. UK), which is below the EU’s 50%+1 share requirement; ready to activate “no deal” contingency plan, suspending non-EU voting rights on a last in first out basis.
Berry Group says 793p/share takeover offer for RPC is final and will not be increased unless RPC receives a better third-party bid. Takeover expected to conclude Q3.
G4S provides 2017-18 breakdown of underlying quarterly organic growth: Secure Solutions (average 3.1% per quarter), Cash Solutions (0.1%), Cash Solutions ex-RCS & NA (0.8%) and Group (2.3%).
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| NEXT | NXT | 0.0% | 0.0% | -6.0% |
| HALMA | HLMA | 0.1% | 0.7% | -1.6% |
| PERSIMMON | PSN | -6.3% | -4.4% | -7.6% |
| VODAFONE | VOD | 0.8% | 1.6% | -0.9% |
| TED BAKER | TED | -11.3% | -5.8% | -13.2% |
| IG | IGG | -10.9% | -8.3% | -14.8% |
| RENISHAW | RSW | -10.9% | -8.7% | -15.0% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research